{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:22:45Z","timestamp":1768508565679,"version":"3.49.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Lung cancer screening guidelines abroad predominantly rely on smoking pack-years and age, Chinese guidelines uniquely incorporate non-smoking risk factors, though empirical validation remains limited. This study compared low-dose computed tomography (LDCT) screening participation and effectiveness between non-smoking females and males in real-world settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used data from the Cancer Screening Program in Urban China (CanSPUC) in Zhejiang Province, spanning from April 2019 to December 2024. Eligible participants were aged 45 to 74 and were evaluated for a high risk for lung cancer. We stratified the population into three comparison groups: non-smoking females, non-smoking males and smoking males. Four key screening metrics were compared between groups: LDCT adherence rate, positive rate, lung cancer detection rate and false-positive rate. Multivariable robust (modified) Poisson regression was used to estimate adjusted risk ratios (aRRs) between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 88,797 participants aged 45 to 74 years were included in this study, comprising 43,604 non-smoking females and 45,193 males (6988 non-smokers). The overall LDCT participation rate was 61.2%, with a positive rate of 5.6%, lung cancer detection rate was 1.5%, and a false-positive rate of 95.2%. After adjustment for age, BMI, educational level, passive smoking, occupational exposure to hazardous substances, history of tuberculosis; history of COPD; family history of lung cancer, hypertension; hyperlipidemia and diabetes, smoking males showed significantly higher rates than non-smoking females in LDCT adherence (aRR=1.22, 95% CI 1.20-1.24), positive findings (aRR=1.12, 95% CI 1.04-1.20), and lung cancer detection (aRR=1.36, 95% CI 1.17-1.57). Conversely, non-smoking males demonstrated lower adherence (aRR=0.82, 95% CI 0.79-0.85), fewer positive findings (aRR=0.83, 95% CI 0.70-0.98), and reduced lung cancer detection (aRR=0.57, 95% CI 0.37-0.86) compared to non-smoking females. False-positive rates showed no significant differences across groups. During risk stratification of non-smoking females, both passive smoking (aRR=1.46, 95% CI 1.08-2.01) and hormonal abnormalities (aRR=1.39, 95% CI 1.11-1.75) were identified as independent risk factors for lung cancer, with no significant interaction observed between these factors. Multivariable analyses revealed that high-risk non-smoking females with both passive smoking and hormonal abnormalities showed no statistically significant differences in lung cancer detection rates (vs. all males: aRR=0.93, 95% CI 0.77\u20131.13; vs. smoking males: aRR=0.88, 95% CI 0.72\u20131.07) or false-positive rates (vs. all males: aRR=0.95, 95% CI 0.85\u20131.07; vs. smoking males: aRR=0.96, 95% CI 0.85\u20131.07) compared to male populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary, current lung cancer screening criteria demonstrate limited applicability in female populations, as evidenced by significantly lower LDCT adherence, positive rates, and detection rates among non-smoking females compared to smoking males. Critically, we identified a well-defined subgroup of non-smoking females characterized by combined passive smoking and hormonal abnormalities. This subgroup exhibited screening outcomes that were not statistically significantly different from those observed in male populations. These findings support the development of more precise, risk-stratified screening criteria that better account for sex-specific differences in lung cancer risk and clinical presentation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1755209","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:14:00Z","timestamp":1768454040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of low-dose CT lung cancer screening among high-risk non-smoking female subgroups and males in China"],"prefix":"10.3389","volume":"15","author":[{"given":"Yumeng","family":"Ding","sequence":"first","affiliation":[{"name":"School of Public Health, Nanjing Medical University","place":["Nanjing, China"]},{"name":"Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanting","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Gong","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Centre for Disease Control and Prevention","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingbin","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Cheng","sequence":"additional","affiliation":[{"name":"School of Public Health, Nanjing Medical University","place":["Nanjing, China"]},{"name":"Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00164-8","article-title":"Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Center"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00844-0","article-title":"Lung cancer in patients who have never smoked - an emerging disease","volume":"21","author":"LoPiccolo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.17695","article-title":"Lung cancer in nonsmoking individuals: A review","volume":"334","author":"Murphy","year":"2025","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"New Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112152-20210119-00060","article-title":"China guideline for the screening and early detection of lung cancer(2021, Beijing)","volume":"43","author":"He","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese J oncology]"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US preventive services task force recommendation statement","volume":"325","author":"Krist","year":"2021","journal-title":"Jama"},{"key":"B10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3322\/caac.21811","article-title":"Screening for lung cancer: 2023 guideline update from the American Cancer Society","volume":"74","author":"Wolf","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.4017","article-title":"Non-risk-based lung cancer screening with low-dose computed tomography","volume":"333","author":"Li","year":"2025","journal-title":"Jama"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(23)00338-7","article-title":"Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study","volume":"12","author":"Chang","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B13","article-title":"Preliminary results from the female asian nonsmoker screening study (FANSS) [oral presentation]","volume-title":"2023 World Conference on Lung Cancer (WCLC) - Abstracts","author":"Shum","year":"2023"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.11.002","article-title":"Role of low-dose computerized tomography in lung cancer screening among never-smokers","volume":"14","author":"Kang","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.02.013","article-title":"Overdiagnosis of lung cancer due to the introduction of low-dose computed tomography in average-risk populations in the people\u2019s republic of China","volume":"20","author":"Xie","year":"2025","journal-title":"J Thorac Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12885-024-12133-9","article-title":"Reproductive factors and risk of lung cancer among 300,000 Chinese female never-smokers: evidence from the China Kadoorie Biobank study","volume":"24","author":"Elbasheer","year":"2024","journal-title":"BMC Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(16)30200-4","article-title":"Lung cancer screening: latest developments and unanswered questions","volume":"4","author":"van der Aalst","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2019039","DOI":"10.1001\/jamanetworkopen.2020.19039","article-title":"Evaluation of a low-dose computed tomography lung cancer screening program in Henan, China","volume":"3","author":"Guo","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B20","article-title":"Preliminary results of cancer screening program in ur-ban areas in Zhejiang province from 2013 to 2018","volume":"29","author":"Wang","year":"2020","journal-title":"Zhongguo Zhong Liu [China Cancer]"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00560-9","article-title":"One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1001\/jama.2013.4324","article-title":"JAMA patient page. Lung cancer screening","volume":"309","author":"Boiselle","year":"2013","journal-title":"Jama"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2010.08.022","article-title":"Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry","volume":"18","author":"Oda","year":"2011","journal-title":"Acad Radiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(14)70389-4","article-title":"Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening","volume":"15","author":"Horeweg","year":"2014","journal-title":"Lancet Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15071348","article-title":"Meta-analysis and systematic review in environmental tobacco smoke risk of female lung cancer by research type","volume":"15","author":"Ni","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.11.014","article-title":"Associations between sex-specific reproductive factors and risk of new-onset lung cancer among female patients","volume":"166","author":"Zhang","year":"2024","journal-title":"Chest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jtho.2023.01.094","article-title":"Low-dose computed tomography (LDCT) lung cancer screening in asian female never-smokers is as efficacious in detecting lung cancer as in asian male ever-smokers: A systematic review and meta-analysis","volume":"18","author":"Triphuridet","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e70021","DOI":"10.1002\/cai2.70021","article-title":"A study protocol for a comprehensive evaluation of two artificial intelligence-based tools in title and abstract screening for the development of evidence-based cancer guidelines","volume":"4","author":"Yao","year":"2025","journal-title":"Cancer Innovat"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70019","DOI":"10.1002\/cai2.70019","article-title":"Artificial intelligence-based methods: the path forward in achieving equity in lung cancer screening and evaluation","volume":"4","author":"Kuperberg","year":"2025","journal-title":"Cancer Innovat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35309","article-title":"Estrogen, estrogen receptor and the tumor microenvironment of NSCLC","volume":"156","author":"Diao","year":"2025","journal-title":"Int J Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1755209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:14:02Z","timestamp":1768454042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1755209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":31,"alternative-id":["10.3389\/fonc.2025.1755209"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1755209","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"1755209"}}